2023. Biologics and small molecules treatment for moderate-to-severe atopic dermatitis patients with comorbid conditions and special populations: an Italian perspective. Dermatology Reports. 16, 2 (Sep. 2023). DOI:https://doi.org/10.4081/dr.2023.9839.